Hansa Biopharma To Raises $34.5M Through Directed Issue
Hansa Biopharma AB said Friday that it plans to raise 372 million Swedish kronor ($35 million) through selling shares to institutional investors as the company weighs listing in the U.S....To view the full article, register now.
Already a subscriber? Click here to view full article